Biography

Taosheng Chen completed his Ph.D. from the University of Vermont, and postdoctoral studies from the University of Virginia. He is an Associate Member (Associate Professor) and Director of the High Throughput Bioscience Center at St. Jude Children’s Research Hospital. Prior to joining St Jude, Taosheng was a Senior Research Investigator at Bristol-Myers Squibb, and a Research Scientist at SAIC-Frederick, National Cancer Institute. Taosheng serves on the Editorial Boards of several journals, and on NIH Grant Review Panels. He has authored more than 80 publications. His research laboratory studies the roles of nuclear receptors in therapeutic efficacy and toxic effects

Research Interest

Regulation of PXR and CAR in drug toxicity, drug resistance and human diseases Regulation of PAX3-FOXO1 and muscle differentiation in the development of rhabdomyosarcoma Development of drug discovery technologies High throughput screening (HTS) and high content screening (HCS)